← Back to Analyst Consensus 
GLSI Buy
Greenwich LifeSciences, Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 21, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Dec 30, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $50 | 44% |
| Apr 21, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $39 | 44% |
| Feb 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $38 | 44% |
| Aug 23, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $38 | 44% |
| May 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $36 | 44% |
| Feb 28, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $36 | 44% |
| Feb 20, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $36 | 44% |
| Apr 10, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $38 | 44% |
| Sep 1, 2021 | HC Wainwright & Co. | initiate | — → Buy | $78 | 44% |
| Jan 27, 2021 | Aegis Capital | initiate | — → Buy | $75 | — |
| Jan 26, 2021 | Aegis Capital | initiate | — → Buy | $75 | — |
Price Target Trend
Apr 22, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days